Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001790340-25-000104
Filing Date
2025-08-13
Accepted
2025-08-13 16:25:10
Documents
65
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20250630.htm   iXBRL 10-Q 1438512
2 EX-31.1 imrx-20250630xex311.htm EX-31.1 10101
3 EX-31.2 imrx-20250630xex312.htm EX-31.2 10216
4 EX-32.1 imrx-20250630xex321.htm EX-32.1 5044
5 EX-32.2 imrx-20250630xex322.htm EX-32.2 5180
  Complete submission text file 0001790340-25-000104.txt   5785992

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20250630.xsd EX-101.SCH 35382
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imrx-20250630_cal.xml EX-101.CAL 52718
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imrx-20250630_def.xml EX-101.DEF 187156
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20250630_lab.xml EX-101.LAB 502272
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20250630_pre.xml EX-101.PRE 359079
68 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20250630_htm.xml XML 559389
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 251212052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)